Company profile - Brighter Actiste feature image - 16092019 - JPG



SEK954.9m market cap

SEK11.14 last close

Brighter is a Swedish healthtech company focused on the development and commercialisation of self-monitoring and self-treatment health solutions for diabetes.

Investment summary

Brighter is a healthtech company developing solutions for chronic diseases. Its initial strategy is the market introduction of Actiste, a remote monitoring and treatment service for diabetes which recently received two CE marks (Actiste is regulated under both the EU Medical Devices Directive and the In Vitro Diagnostics Directive). The service includes a unique patented device that integrates all the essential features for daily diabetes management, a blood glucose meter, a lancer, an insulin injection pen, into a single unit with built-in mobile connection, and a digital platform for analysing and sharing data with family & friends, healthcare providers and other relevant stakeholders.

Y/E Dec
Revenue (SEKm)
EPS (öre)
P/E (x)
P/CF (x)
2017A 1.4 (19.7) (22.8) (40.00) N/A N/A
2018A 1.1 (44.2) (48.8) (74.00) N/A N/A
2019E 0.5 (63.8) (77.4) (95.87) N/A N/A
2020E 24.5 (77.0) (91.4) (111.24) N/A N/A
Last updated on 19/09/2019
Industry outlook

In 2017, costs attributed to diagnosed diabetes and associated complications, such as cardiovascular disease and nephropathy, totalled $327bn in the US. Patient opinions of treatment burden are heavily correlated with adherence to self-care.

Last updated on 19/09/2019
Share price graph
Balance sheet
Forecast net debt (SEKm) 40.3
Forecast gearing ratio (%) 33
Price performance
Actual 12.8 (5.6) 13.1
Relative* 6.1 (8.3) 8.5
52-week high/low SEK14.7/SEK7.9
*% relative to local index
Key management
Truls Sjostedt CEO
Henrik Norström Chief Operating Officer
Petra Kaur Chief Marketing and Communications Officer